Epistaxis management on COVID-19-positive patients: Our early case experience and treatment

Samba Siva R Bathula; Tyler Patrick; Luxman Srikantha

doi:10.1002/ccr3.3137

Epistaxis management on COVID-19-positive patients: Our early case experience and treatment

Clin Case Rep. 2020 Jul 21;8(11):2195-2198. doi: 10.1002/ccr3.3137. eCollection 2020 Nov.

Authors

Samba Siva R Bathula¹, Tyler Patrick¹, Luxman Srikantha¹

Affiliation

¹ Department of Otolaryngology - Head and Neck Surgery Detroit Medical Center Detroit MI USA.

Abstract

Epistaxis management on COVID-19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with absorbable material to prevent COVID-19 transmission to surrounding healthcare workers.

Keywords: COVID‐19; Merocel; epistaxis; surgicel.

Publication types

Case Reports